Sunday, July 23, 2017

CBS Sunday Morning on 23 July 2017 repeats work on immunotherapy treatments for cancer

On July 23, 2017, CBS Sunday Morning repeated a March 12 broadcast on cancer wherein CBS New chief medical correspondent Dr.Jon LaPook (not Jane Pauley) hosted a special edition of CBS Sunday Morning, devoted to cancer research and treatment. The Beyond Cancer edition featured Dr. LaPook’s report on the promising field of immunotherapy, in turn featuring work of Dr. Steven Rosenberg of NIH/NCI. Other portions included Rita Braver‘s interview with singer-songwriter and breast cancer survivor Sheryl Crow and Erin Moriarty on women who decided to forego breast reconstruction surgery following a double mastectomy

Note an August 2016 post
USPTO Offers a Fast Track to Cancer Immunotherapy Patents

AND from MoFo on 23 June 2017:

The United States Patent and Trademark Office (PTO) issued a Notice today extending the Cancer Immunotherapy Pilot
Program (Pilot Program), also known as "Patents 4 Patients." The Pilot Program, which accelerates the examination of
patent applications directed to cancer immunotherapy methods, will now expire on December 31, 2018, absent further
The PTO implemented the Pilot Program a year ago as part of the National Cancer Moonshot initiative. That initiative seeks
to transform cancer research and care by substantially accelerating efforts to combat cancer over the next five years.
Because the patent system is a driver of innovation, the program aims to advance cancer treatments so that they may
reach patients faster. Specifically, the Pilot Program seeks to achieve allowance of meritorious patents within 12 months
from filing a petition under the program.
There were more than 900 immunotherapy patent applications pending when the Pilot Program was first implemented. That
number likely has grown substantially due to the innovations in the immuno-oncology field. In its Notice, the PTO indicated
that 80 petitions have been requested, to date, and nine eligible patents have been granted under the Pilot Program.


Post a Comment

<< Home